RDInvesting Provides Stocks Research on Anika Therapeutics and Array Biopharma
Continue ReadingTag: research-driven-investing
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
RDInvesting Provides Stocks Research on ADVENTRX Pharmaceuticals and Corcept Therapeutics
Continue Reading
Natural Gas Prices Rebound on Improved Heating Demand — EIA Projects Prices to Average $3.53 per MMBtu in 2013
RDInvesting Provides Stock Research on EnCana and WPX Energy
Continue Reading
EIA-s Short-Term Energy Outlook Predicts Natural Gas Prices to Average $3.53 per MMBtu in 2013 and $3.84 per MMBtu in 2014
RDInvesting Provides Stock Research on Devon Energy and QEP Resources
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
RDInvesting Provides Stocks Research on Sangamo Biosciences and Spectrum Pharmaceuticals
Continue Reading
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
RDInvesting Provides Stocks Research on Arrowhead Research and MediciNova
Continue Reading
According to the EIA-s Short-Term Energy Outlook Natural Gas to Average $3.53 per MMBtu in 2013
RDInvesting Provides Stock Research on Chesapeake Energy and SandRidge Energy
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 than the Year Previous
RDInvesting Provides Stocks Research on Vical and Zalicus
Continue Reading
Natural Gas Prices Trending Upwards on Improved Heating Demand
RDInvesting Provides Stock Research on Quicksilver Resources and Southwestern Energy
Continue Reading
An Estimated 1.2 Million New Vehicles Were Sold in February — a 15% Sequential Increase
RDInvesting Provides Stock Research on Ford and General Motors
Continue Reading